Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study

Erstveröffentlichung

2020

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Davids, Matthew S.

Kuss, Bryone J.

Hillmen, Peter

Montillo, Marco

Moreno, Carol

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

Clinical Cancer Research ; 26 (2020), 9. - S. 2096-2103. - ISSN 1078-0432. - eISSN 1557-3265

Link to publication

https://dx.doi.org/10.1158/1078-0432.CCR-19-3061

Keywords

CHRONIC LYMPHOCYTIC-LEUKEMIA; OPEN-LABEL; VENETOCLAX; INHIBITOR; IBRUTINIB

Dewey Decimal Group

DDC 610 / Medicine & health

---

Metadata

Show full item record